Project personalized nutrition market to $48.57B

Personalized nutrition is the business of turning your own data into food advice — blood sugar, DNA, microbiome, labs, habits, sometimes all of it at once. The pitch is simple: stop giving everyone the same supplement stack and the same meal plan. What changed is that the market now has a much bigger number attached to it. Grand View Research’s latest report puts the category at $15.97 billion in 2025 and says it could reach $48.57 billion by 2033. (grandviewresearch.com) ### What counts as personalized nutrition? It’s a broad bucket. Some companies sell quizzes and custom vitamin packs. Others use DNA tests, blood markers, continuous glucose monitors, or microbiome analysis to shape meal plans and supplements. Grand View splits the market across ingredients, dosage forms, channels, age groups, and regions — which tells you this is no longer just a tiny direct-to-consumer experiment. (grandviewresearch.com) ### Why is the forecast getting so big? Because the inputs are getting cheaper, easier, and more useful. CGMs are no longer just a diabetes device in the public mind — they’ve become a feedback tool for food decisions and metabolic health. Abbott added a Libre Assist feature in January 2026 that rates foods by likely gluco(grandviewresearch.com)m a static PDF into a live loop. (abbott.mediaroom.com) ### Where does AI fit in? Basically everywhere the category touches behavior. Grand View pegs the separate AI-in-personalized-nutrition market at $1.54 billion in 2025, reaching $10.21 billion by 2033. That doesn’t mean AI replaces dietitians or clinicians. It means software can now turn meal logs, wearable data, lab results, and glucose trends into recommendations people might actually use day to day. (grandviewresearch.com) ### Why does the microbiome matter here? Because one of the biggest promises in nutrition is explaining why the same food hits different people differently. A 2025 Nature Communications study tied gut microbiota composition and metabolic status to how well people with prediabetes responded to dietary fiber, then built a model to gu(grandviewresearch.com)iology, not averages, drives the recommendation. (nature.com) ### What are companies actually selling? Not just pills. They’re selling programs. GenoPalate bundles DNA and blood testing with coaching, meal plans, and personalized supplements. Levels sells metabolic-health guidance built around CGM data and labs. True Nutrition lets customers build custom protein powders ingredient by ingredient. The common thread is recurring revenue — subscri(nature.com)lls. (genopalate.com) ### Why are protein products a real angle? Because protein is easy to personalize around a goal. Muscle retention on GLP-1 drugs, sports recovery, healthy aging, menopause, and metabolic health all create different formulations and serving targets. That makes protein more than a commodity tub on a shelf. It becomes a tailored product with a reason to subscribe, especially when it plugs into coaching or biomarker tracking. (nutritioninsight.com) ### What’s the catch? A lot of this market still runs ahead of hard clinical proof. Some tools are genuinely useful. Some are polished consumer wellness with thinner evidence. Even the market forecasts vary a lot — one firm sees $48.57 billion by 2033, another sees $47.62 billion, another $41.9 billion by 2034, and another $30.94 billion by 2030. The direction looks clear, but the exact size is still estimate territory. (grandviewresearch.com) ### So what’s the bottom line? This market is getting bigger because nutrition is becoming a data product. The winners will probably be the companies that can connect biology, behavior, and replenishable products without overpromising the science. $48.57 billion is the headline number. The real story is that food advice is turning into software, monitoring, and subscriptions. (grandviewresearch.com)